Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KAIRA, Kyoichi")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 52

  • Page / 3
Export

Selection :

  • and

Barium sulphate aspirationKAIRA, Kyoichi; TAKISE, Atsushi; GOTO, Tomoki et al.Lancet (British edition). 2004, Vol 364, Num 9452, issn 0140-6736, p. 2220Article

Assessment of Therapy Response in Lung Cancer With 18F-α-Methyl Tyrosine PETKAIRA, Kyoichi; ORIUCHI, Noboru; YANAGITANI, Noriko et al.American journal of roentgenology (1976). 2010, Vol 195, Num 5, pp 1204-1211, issn 0361-803X, 8 p.Article

Small cell carcinoma of the larynx in a long- term survivor of small-cell lung cancerKAIRA, Kyoichi; ISHIZUKA, Tamotsu; SAHARA, Naondo et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2961-2963, issn 0732-183X, 3 p.Article

Forearm Muscle Metastasis as an Initial Clinical Manifestation of Lung CancerKAIRA, Kyoichi; ISHIZUKA, Tamotsu; YANAGITANI, Noriko et al.Southern medical journal (Birmingham, Ala. Print). 2009, Vol 102, Num 1, pp 79-81, issn 0038-4348, 3 p.Article

Prognostic Significance of Thymidylate Synthase Expression in the Adjuvant Chemotherapy after Resection for Pulmonary Metastases from Colorectal CancerKAIRA, Kyoichi; OKUMURA, Takehiro; OHDE, Yasuhisa et al.Anticancer research. 2011, Vol 31, Num 9, pp 2763-2771, issn 0250-7005, 9 p.Article

Long-term survivors of more than 5 years in advanced non-small cell lung cancerKAIRA, Kyoichi; TAKAHASHI, Toshiaki; MURAKAMI, Haruyasu et al.Lung cancer. 2010, Vol 67, Num 1, pp 120-123, issn 0169-5002, 4 p.Article

MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinomaKAIRA, Kyoichi; MURAKAMI, Haruyasu; SERIZAWA, Masakuni et al.Virchows Archiv. 2011, Vol 458, Num 5, pp 615-620, issn 0945-6317, 6 p.Article

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancerIMAI, Hisao; KAIRA, Kyoichi; ORIUCHI, Noboru et al.Histopathology. 2009, Vol 54, Num 7, pp 804-813, issn 0309-0167, 10 p.Article

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancerSUNAGA, Noriaki; ORIUCHI, Noboru; KAIRA, Kyoichi et al.Lung cancer. 2008, Vol 59, Num 2, pp 203-210, issn 0169-5002, 8 p.Article

Correlation between computed tomography findings and epidermal growth factor receptor and KRAS gene mutations in patients with pulmonary adenocarcinomaSUGANO, Masayuki; SHIMIZU, Kimihiro; NAKANO, Tetsuhiro et al.Oncology reports. 2011, Vol 26, Num 5, pp 1205-1211, issn 1021-335X, 7 p.Article

Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesotheliomaKAIRA, Kyoichi; SERIZAWA, Masakuni; KOH, Yasuhiro et al.European journal of cancer (1990). 2012, Vol 48, Num 8, pp 1244-1254, issn 0959-8049, 11 p.Article

Clinicopathological Features of Lung Adenocarcinoma With KRAS MutationsKAKEGAWA, Seiichi; SHIMIZU, Kimihiro; SUGANO, Masayuki et al.Cancer. 2011, Vol 117, Num 18, pp 4257-4266, issn 0008-543X, 10 p.Article

Prolonged Intrahepatic Cholestasis After Exposure to LoxoprofenICHIKAWA, Takeshi; SATO, Hiroko; KAIRA, Kyoichi et al.Clinical therapeutics. 2008, Vol 30, Num 12, pp 2402-2406, issn 0149-2918, 5 p.Article

Diagnostic usefulness of fluorine-18-α-methyltyrosine positron emission tomography in combination with 18F -fluorodeoxyglucose in sarcoidosis patientsKAIRA, Kyoichi; ORIUCHI, Noboru; OTANI, Yoshimi et al.Chest. 2007, Vol 131, Num 4, pp 1019-1027, issn 0012-3692, 9 p.Article

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancersKAIRA, Kyoichi; SUNAGA, Noriaki; TOMIZAWA, Yoshio et al.International journal of oncology. 2007, Vol 31, Num 1, pp 169-173, issn 1019-6439, 5 p.Article

Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancerKAIRA, Kyoichi; SERIZAWA, Masakuni; YAMAMOTO, Nobuyuki et al.Lung cancer. 2014, Vol 83, Num 2, pp 197-204, issn 0169-5002, 8 p.Article

Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reportsSHUKUYA, Takehito; TAKAHASHI, Toshiaki; ENDO, Masahiro et al.Cancer science. 2011, Vol 102, Num 5, pp 1032-1037, issn 1347-9032, 6 p.Article

L-Type Amino Acid Transporter 1 (LAT1) Expression in Malignant Pleural MesotheliomaKAIRA, Kyoichi; ORIUCHI, Noboru; KANAI, Yoshikatsu et al.Anticancer research. 2011, Vol 31, Num 12, pp 4075-4082, issn 0250-7005, 8 p.Article

Gefitinib Plus Paclitaxel after Failure of Gefitinib in Non-small Cell Lung Cancer Initially Responding to GefitinibSHUKUYA, Takehito; TAKAHASHI, Toshiaki; ENDO, Masahiro et al.Anticancer research. 2009, Vol 29, Num 7, pp 2747-2751, issn 0250-7005, 5 p.Article

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinomaKAIRA, Kyoichi; ORIUCHI, Noboru; MORI, Masatomo et al.Lung cancer. 2009, Vol 66, Num 1, pp 120-126, issn 0169-5002, 7 p.Article

Expression of 4F2hc (CD98) in pulmonary neuroendocrine tumorsKAIRA, Kyoichi; OHDE, Yasuhisa; KONDO, Haruhiko et al.Oncology reports. 2011, Vol 26, Num 4, pp 931-937, issn 1021-335X, 7 p.Article

Relationship between LAT1 Expression and Response to Platinum-based Chemotherapy in Non-small Cell Lung Cancer Patients with Postoperative RecurrenceKAIRA, Kyoichi; TAKAHASHI, Toshiaki; NAKAJIMA, Takashi et al.Anticancer research. 2011, Vol 31, Num 11, pp 3775-3782, issn 0250-7005, 8 p.Article

Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancerKAIRA, Kyoichi; NAITO, Tateaki; TSUYA, Asuka et al.Lung cancer. 2010, Vol 68, Num 1, pp 99-104, issn 0169-5002, 6 p.Article

Inhibition of L-type Amino Acid Transporter 1 Has Antitumor Activity in Non-small Cell Lung CancerIMAI, Hisao; KAIRA, Kyoichi; NAKAJIMA, Takashi et al.Anticancer research. 2010, Vol 30, Num 12, pp 4819-4828, issn 0250-7005, 10 p.Article

Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux diseaseSHIMIZU, Yasuo; DOBASHI, Kunio; MORI, Masatomo et al.Respiration (Basel). 2007, Vol 74, Num 5, pp 558-564, issn 0025-7931, 7 p.Article

  • Page / 3